Daily News Podcast

SGLT2s for heart failure first, diabetes second


 

For patients with systemic heart failure but without diabetes, oral SGLT2s are the focus of multiple ongoing phase 3 clinical trials. Also today, influenza activity hits a seasonal high, the U.S. Supreme Court halts a Louisiana abortion law from taking effect, and cilostazol plus aspirin or clopidogrel reduces the risk of recurrent stroke.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale
MDedge Internal Medicine
Socioeconomic status, race found to impact CPAP compliance
MDedge Internal Medicine
Adolescence does not rule out bullous pemphigoid
MDedge Internal Medicine
­­ADT harms likely limited to men with CV comorbidities
MDedge Internal Medicine
Supreme Court halts Louisiana abortion law from taking effect
MDedge Internal Medicine
Marijuana smoking is an independent risk factor for lung disease in HIV+
MDedge Internal Medicine
In search of an ear
MDedge Internal Medicine
Flu activity hits seasonal high
MDedge Internal Medicine
Most U.S. tPA-eligible stroke patients now get treated within an hour
MDedge Internal Medicine
Hidradenitis suppurativa linked to increased lymphoma risk
MDedge Internal Medicine